|
1
|
Kendrick J and Chonchol M: The role of
phosphorus in the development and progression of vascular
calcification. Am J Kidney Dis. 58:826–834. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pun PH, Smarz TR, Honeycutt EF, Shaw LK,
Al-Khatib SM and Middleton JP: Chronic kidney disease is associated
with increased risk of sudden cardiac death among patients with
coronary artery disease. Kidney Int. 76:652–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qunibi WY: Consequences of
hyperphosphatemia in patients with end-stage renal disease (ESRD).
Kidney Int Suppl. 90:S8–S12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moe SM and Chen NX: Pathophysiology of
vascular calcification in chronic kidney disease. Circ Res.
95:560–567. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ossareh S: Vascular calcification in
chronic kidney disease: Mechanisms and clinical implications. Iran
J Kidney Dis. 5:285–299. 2011.PubMed/NCBI
|
|
6
|
Neven E, De Schutter TM, De Broe ME and
D'Haese PC: Cell biological and physicochemical aspects of arterial
calcification. Kidney Int. 79:1166–1177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Persy V and D'Haese P: Vascular
calcification and bone disease: The calcification paradox. Trends
Mol Med. 15:405–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gutierrez OM, Mannstadt M, Isakova T,
Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner
H and Wolf M: Fibroblast growth factor 23 and mortality among
patients undergoing hemodialysis. N Engl J Med. 359:584–592. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lomashvili KA, Monier-Faugere MC, Wang X,
Malluche HH and O'Neill WC: Effect of bisphosphonates on vascular
calcification and bone metabolism in experimental renal failure.
Kidney Int. 75:617–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roh J, Chang CL, Bhalla A, Klein C and Hsu
SY: Intermedin is a calcitonin/calcitonin gene-related peptide
family peptide acting through the calcitonin receptor-like
receptor/receptor activity-modifying protein receptor complexes. J
Biol Chem. 279:7264–7274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takei Y, Inoue K, Ogoshi M, Kawahara T,
Bannai H and Miyano S: Identification of novel adrenomedullin in
mammals: A potent cardiovascular and renal regulator. FEBS Lett.
556:53–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong Y, Hay DL, Quirion R and Poyner DR:
The pharmacology of adrenomedullin 2/intermedin. Br J Pharmacol.
166:110–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Peng DQ, Zhang J, Song JQ, Teng X,
Yu YR, Tang CS and Qi YF: Extracellular signal-regulated kinase 1/2
activation is involved in intermedin1-53 attenuating myocardial
oxidative stress injury induced by ischemia/reperfusion. Peptides.
33:329–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang JR, Duan XH, Zhang BH, Teng X, Zhou
YB, Liu Y, Yu YR, Zhu Y, Tang CS and Qi YF: Intermedin1-53
attenuates vascular smooth muscle cell calcification by inhibiting
endoplasmic reticulum stress via cyclic adenosine
monophosphate/protein kinase A pathway. Exp Biol Med (Maywood).
238:1136–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang JR, Guo J, Wang Y, Hou YL, Lu WW,
Zhang JS, Yu YR, Xu MJ, Liu XY, Wang XJ, et al: Intermedin1-53
attenuates vascular calcification in rats with chronic kidney
disease by upregulation of α-Klotho. Kidney Int. 89:586–600. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grossini E, Molinari C, Mary DA, Uberti F,
Caimmi PP and Vacca G: Intracoronary intermedin 1–47 augments
cardiac perfusion and function in anesthetized pigs: Role of
calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide
release. J Appl Physiol (1985). 107:1037–1050. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Golovina VA and Blaustein MP: Preparation
of primary cultured mesenteric artery smooth muscle cells for
fluorescent imaging and physiological studies. Nat Protoc.
1:2681–2687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Willems BA, Furmanik M, Caron MM, Chatrou
ML, Kusters DH, Welting TJ, Stock M, Rafael MS, Viegas CS, Simes
DC, et al: Ucma/GRP inhibits phosphate-induced vascular smooth
muscle cell calcification via SMAD-dependent BMP signalling. Sci
Rep. 8:49612018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Li J, Liu J, Xu M, Tong X and Wang
J: Chlorogenic acid prevents isoproterenol-induced DNA damage in
vascular smooth muscle cells. Mol Med Rep. 14:4063–4068. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu D, Mackenzie NC, Millán JL,
Farquharson C and MacRae VE: The appearance and modulation of
osteocyte marker expression during calcification of vascular smooth
muscle cells. PLoS One. 6:e195952011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu H, Zhang W, Qiao Y, Jiang X, Liu X and
Ding C: Antibacterial activity and increased bone marrow stem cell
functions of Zn-incorporated TiO2 coatings on titanium. Acta
Biomater. 8:904–915. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leopold JA: Vascular calcification:
Mechanisms of vascular smooth muscle cell calcification. Trends
Cardiovasc Med. 25:267–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moe SM, O'Neill KD, Duan D, Ahmed S, Chen
NX, Leapman SB, Fineberg N and Kopecky K: Medial artery
calcification in ESRD patients is associated with deposition of
bone matrix proteins. Kidney Int. 61:638–647. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wallin R, Wajih N, Greenwood GT and Sane
DC: Arterial calcification: A review of mechanisms, animal models,
and the prospects for therapy. Med Res Rev. 21:274–301. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakagawa Y, Ikeda K, Akakabe Y, Koide M,
Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S,
Yamada H, et al: Paracrine osteogenic signals via bone
morphogenetic protein-2 accelerate the atherosclerotic intimal
calcification in vivo. Arterioscler Thromb Vasc Biol. 30:1908–1915.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fakhry M, Roszkowska M, Briolay A,
Bougault C, Guignandon A, Diaz-Hernandez JI, Diaz-Hernandez M,
Pikula S, Buchet R, Hamade E, et al: TNAP stimulates vascular
smooth muscle cell trans-differentiation into chondrocytes through
calcium deposition and BMP-2 activation: Possible implication in
atherosclerotic plaque stability. Biochim Biophys Acta Mol Basis
Dis. 1863:643–653. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Giachelli CM: Vascular calcification
mechanisms. J Am Soc Nephrol. 15:2959–2964. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Engelse MA, Neele JM, Bronckers AL,
Pannekoek H and de Vries CJ: Vascular calcification: Expression
patterns of the osteoblast-specific gene core binding factor
alpha-1 and the protective factor matrix gla protein in human
atherogenesis. Cardiovasc Res. 52:281–289. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun Y, Byon CH, Yuan K, Chen J, Mao X,
Heath JM, Javed A, Zhang K, Anderson PG and Chen Y: Smooth muscle
cell-specific runx2 deficiency inhibits vascular calcification.
Circ Res. 111:543–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tyson KL, Reynolds JL, McNair R, Zhang Q,
Weissberg PL and Shanahan CM: Osteo/chondrocytic transcription
factors and their target genes exhibit distinct patterns of
expression in human arterial calcification. Arterioscler Thromb
Vasc Biol. 23:489–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Y, Hu Y, Yang L, Zhou J, Tang Y,
Zheng L and Qin P: Runx2 alleviates high glucose-suppressed
osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
Cell Biol Int. 41:822–832. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Endres M, Hutmacher DW, Salgado AJ, Kaps
C, Ringe J, Reis RL, Sittinger M, Brandwood A and Schantz JT:
Osteogenic induction of human bone marrow-derived mesenchymal
progenitor cells in novel synthetic polymer-hydrogel matrices.
Tissue Eng. 9:689–702. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoshi K, Ejiri S and Ozawa H:
Localizational alterations of calcium, phosphorus, and
calcification-related organics such as proteoglycans and alkaline
phosphatase during bone calcification. J Bone Miner Res.
16:289–298. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shioi A, Nishizawa Y, Jono S, Koyama H,
Hosoi M and Morii H: Beta-glycerophosphate accelerates
calcification in cultured bovine vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol. 15:2003–2009. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rong S, Zhao X, Jin X, Zhang Z, Chen L,
Zhu Y and Yuan W: Vascular calcification in chronic kidney disease
is induced by bone morphogenetic protein-2 via a mechanism
involving the Wnt/β-catenin pathway. Cell Physiol Biochem.
34:2049–2060. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kramer I, Halleux C, Keller H, Pegurri M,
Gooi JH, Weber PB, Feng JQ, Bonewald LF and Kneissel M: Osteocyte
Wnt/beta-catenin signaling is required for normal bone homeostasis.
Mol Cell Biol. 30:3071–3085. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y,
Li M, Zhang H, Xue X, Hou Z, et al: Activation of GLP-1 receptor
promotes bone marrow stromal cell osteogenic differentiation
through β-catenin. Stem Cell Reports. 6:579–591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xavier JR, Thakur T, Desai P, Jaiswal MK,
Sears N, Cosgriff-Hernandez E, Kaunas R and Gaharwar AK: Bioactive
nanoengineered hydrogels for bone tissue engineering: A
growth-factor-free approach. ACS Nano. 9:3109–3118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rajamannan NM, Subramaniam M, Caira F,
Stock SR and Spelsberg TC: Atorvastatin inhibits
hypercholesterolemia- induced calcification in the aortic valves
via the Lrp5 receptor pathway. Circulation. 112:5243062005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shao JS, Cheng SL, Pingsterhaus JM,
Charlton-Kachigian N, Loewy AP and Towler DA: Msx2 promotes
cardiovascular calcification by activating paracrine Wnt signals. J
Clin Invest. 115:1210–1220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng SL, Shao JS, Halstead LR,
Distelhorst K, Sierra O and Towler DA: Activation of vascular
smooth muscle parathyroid hormone receptor inhibits
Wnt/beta-catenin signaling and aortic fibrosis in diabetic
arteriosclerosis. Circ Res. 107:271–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J,
Behrmann A, Cheng SL and Towler DA: Aortic Msx2-Wnt calcification
cascade is regulated by TNF-alpha-dependent signals in diabetic
Ldlr-/-mice. Arterioscler Thromb Vasc Biol. 27:2589–2596. 2007.
View Article : Google Scholar : PubMed/NCBI
|
